| Cat. No. |
Product Name |
Information |
| PC-60030 |
Aprocitentan
Endothelin receptor antagonist
|
Aprocitentan (ACT132577) is the major and pharmacologically active metabolite of Macitentan, an orally active, dual endothelin receptor antagonist with IC50s of 3.4 nM and 987 nM for ETA/ETB receptor respectively, inhibits ET-1 and ET-2-induced contractions in functional assays. |
| PC-45639 |
Ro 46-2005
Endothelin receptor antagonist
|
Ro 46-2005 is the first synthetic orally active nonpeptide antagonist of endothelin receptor with equipotent potency (IC50=0.2-0.5 uM) for ETA and ETB. |
| PC-42282 |
Zibotentan
ETA receptor inhibitor
|
Zibotentan (ZD4054) is an orally active, specific Endothelin A receptor (ETA) inhibitor with Ki of 13 nM, shows anticancer effects. |
| PC-45971 |
Sitaxsentan
ETA receptor inhibitor
|
Sitaxsentan (IPI-1040, Sitaxentan) is a potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM. |
| PC-42811 |
Sitaxsentan sodium
ETA receptor inhibitor
|
Sitaxsentan sodium (TBC11251, IPI 1040) is a potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM. |
| PC-28489 |
Nebentan
ETA antagonist
|
Nebentan (Nebentan potassium, YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist, inhibits [125I] endothelin-1 binding to cloned human ETA receptor with Ki of 0.697 nM, >800-fold selective over ETB receoptor. |
| PC-26608 |
PD-156707
ETA receptor antagonist
|
PD-156707 is a potent, selective and orally active non-peptide endothelin-A (ETA) receptor antagonist with Ki of 0.17 nM, >500-fold selective over ET-B receptor. |
| PC-25045 |
Darusentan
ETA receptor antagonist
|
Darusentan (Lu-135252) is a selective endothelin receptor A (ETA) receptor antagonist with binding Ki of 1.4 nM, >100-fold selective over ET-B receptor. |
| PC-25044 |
Macitentan
Endothelin receptor antagonist
|
Macitentan (ACT-064992) is a potent, selective and orally active dual ETA/ETB endothelin receptor antagonist with binding IC50 of 0.5/391 nM for ETA/ETB receptors respectively. |
| PC-25043 |
Pipersentan
ETA receptor antagonist
|
Pipersentan (Diosuxentan) is a potent, selective endothelin receptor A (ETA receptor) antagonist, inhibits binding of 125I-ET-1 toward recombinant ETA receptor with IC50 of 4.44 nM, >1000-fold selective over ETB receptor. |
| PC-24438 |
RES-701-3
ETB receptor antagonist
|
RES-701-3 is a potent, selective antagonist of endothelin type B receptor (ETB receptor) with IC50 of 31.5 nM, with no activity against ETA. RES-701-3 functions as an inverse agonist. |
| PC-23821 |
BQ-788 sodium salt
ETB receptor antagonist
|
BQ-788 sodium salt is a potent, selective endothelin-B receptor (ETB) antagonist with IC50 of 1.2 nM for inhibition of ET-1 binding to human Girardi heart cells, >1000-fold selective over ETA receptor. |